Important Deadlines
Meeting Summary
Neuroimmune interactions are an essential driver of inflammation in the nervous system. While previous efforts have focused on these mechanisms in the brain specifically, recent advances have revealed that these interactions extend throughout the body, playing essential roles in regulating a broad range of physiological systems. Indeed, immune modulation of overall neural circuit function regulates peripheral organ homeostasis.
There is currently no meeting that brings together investigators studying neuroimmune interactions in the context of peripheral organs with those studying the brain, to integrate our understanding of complex, system-wide neural-immune interactions. This meeting will do just that, providing a unique environment to draw cross-disciplinary insights and provide a holistic view of neuroimmune interactions that permeate the body and do not act isolation. In addition, incorporation of industry leaders with academic and clinical experts will spark new ideas and collaborations towards novel neural-immune signaling-targeted therapies against neurodegenerative, neuropsychiatric, and peripheral organ disorders.
This conference will be held jointly with the Keystone Symposium on Neurodegeneration: Linking Cellular Pathways to Therapeutic Strategies to spark innovative cross-disciplinary insights and collaborations towards understanding neuroimmune drivers of neurodegenerative disease and identifying novel therapeutic targets.
Check out the speaker highlights in the video below:
Unique Career Development Opportunities
This meeting will feature a Career Roundtable where trainees and early-career investigators will have the opportunity to interact with field leaders from across academic and industry sectors for essential career development advice and networking opportunities. Find out more about Career Roundtables here: https://www.keystonesymposia.org/diversity/career-development-initiatives
KEYSTONE SYMPOSIA THANKS OUR SPONSOR(S) FOR GENEROUSLY SUPPORTING THIS MEETING:
GRANT RECOGNITION:
Federal Funding provided by the National Institutes of Health:
Funding for this conference was made possible (in part) by grant number 1R13NS137709-01 from The National Institute on Neurological Disorders and Stroke (NINDS). The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of NIH; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
To access the NIH Safe Environment Policy, please click here.